CAC
Cowen and Company Portfolio holdings
AUM
$2.9B
This Quarter Return
+17.46%
1 Year Return
+104.28%
3 Year Return
+119.87%
5 Year Return
+632.2%
10 Year Return
–
AUM
$944M
AUM Growth
+$944M
(-9.7%)
Cap. Flow
-$133M
Cap. Flow
% of AUM
-14.09%
Top 10 Holdings %
Top 10 Hldgs %
51.97%
Holding
845
New
180
Increased
162
Reduced
180
Closed
232
Top Buys
| 1 |
DCP
DCP Midstream, LP
DCP
|
$58.8M |
| 2 |
Immunovant
IMVT
|
$22.2M |
| 3 |
Avidity Biosciences
RNA
|
$11.1M |
| 4 |
LL
LL Flooring Holdings, Inc.
LL
|
$9.12M |
| 5 |
KAIR
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
|
$8.76M |
Top Sells
| 1 |
ARK Innovation ETF
ARKK
|
$131M |
| 2 |
Immunocore
IMCR
|
$34.6M |
| 3 |
FTAI Aviation
FTAI
|
$28.1M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$20.8M |
| 5 |
Automatic Data Processing
ADP
|
$9.25M |
Sector Composition
| 1 | Healthcare | 37.49% |
| 2 | Financials | 14.72% |
| 3 | Materials | 11.14% |
| 4 | Energy | 8.63% |
| 5 | Consumer Discretionary | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Sylvamo
SLVM
$1.86B
| $104M | 10.92% | 2,150,000 | – | – |
|
|
2
Avidity Biosciences
RNA
$5.99B
| $95.2M | 9.95% | 4,288,366 +500,000 | +13% | +$11.1M |
|
|
DCP
3
DELISTED
DCP Midstream, LP
DCP
| $58.8M | 6.15% | +1,516,562 | New | +$58.8M |
|
4
Establishment Labs
ESTA
$1.2B
| $56.2M | 5.88% | 856,654 +20,000 | +2% | +$1.31M |
|
|
CUTR
5
DELISTED
Cutera, Inc.
CUTR
| $29.7M | 3.1% | 671,309 +75,096 | +13% | +$3.32M |
|
6
Innoviz Technologies
INVZ
$335M
| $28.1M | 2.94% | 7,156,390 +2,090,000 | +41% | +$8.21M |
|
7
Adicet Bio
ACET
$59.9M
| $28.1M | 2.94% | 3,143,608 +700,362 | +29% | +$6.26M |
|
8
Sumitomo Mitsui Financial
SMFG
$105B
| $27M | 2.83% | 3,370,730 -306,375 | -8% | -$2.46M |
|
|
AVDL
9
Avadel Pharmaceuticals
AVDL
$1.43B
| $26.7M | 2.79% | 3,732,778 | – | – |
|
|
SCPL
10
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $24.9M | 2.61% | 1,551,246 +80,000 | +5% | +$1.29M |
|
|
11
Immunocore
IMCR
$1.62B
| $23.1M | 2.42% | 405,174 -606,496 | -60% | -$34.6M |
|
|
12
Immunovant
IMVT
$2.56B
| $22.2M | 2.32% | +1,250,000 | New | +$22.2M |
|
13
Rocket Pharmaceuticals
RCKT
$354M
| $21.5M | 2.25% | 1,100,000 +100,412 | +10% | +$1.97M |
|
14
Energy Transfer Partners
ET
$60.8B
| $20.4M | 2.13% | 1,715,000 -160,000 | -9% | -$1.9M |
|
|
PEGR
15
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
| $15.1M | 1.58% | 1,500,000 | – | – |
|
|
HCVIU
16
DELISTED
Hennessy Capital Investment Corp. VI Unit
HCVIU
| $14.8M | 1.54% | 1,500,000 | – | – |
|
17
Cantaloupe
CTLP
$797M
| $12.3M | 1.28% | 2,821,409 -1,033,831 | -27% | -$4.5M |
|
18
Fulcrum Therapeutics
FULC
$351M
| $9.91M | 1.04% | 1,361,169 -986,820 | -42% | -$7.18M |
|
19
ODP
ODP
$610M
| $9.3M | 0.97% | 204,181 -5,500 | -3% | -$250K |
|
20
AdvisorShares Pure US Cannabis ETF
MSOS
$986M
| $9.25M | 0.97% | 1,323,344 +212,900 | +19% | +$1.49M |
|
|
LL
21
DELISTED
LL Flooring Holdings, Inc.
LL
| $9.12M | 0.95% | +1,622,000 | New | +$9.12M |
|
|
KAIR
22
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
| $8.76M | 0.92% | +869,000 | New | +$8.76M |
|
|
NSTC
23
DELISTED
Northern Star Investment Corp. III
NSTC
| $7.39M | 0.77% | +735,000 | New | +$7.39M |
|
|
ALPAU
24
DELISTED
Alpha Healthcare Acquisition Corp. III Units
ALPAU
| $6.99M | 0.73% | 700,000 | – | – |
|
25
Stoke Therapeutics
STOK
$1.08B
| $6.9M | 0.72% | 748,077 -21,092 | -3% | -$195K |
|